Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adductor canal block with ropivacaine after total knee arthroplasty
2009-017794-37Phase 4Completed
- Sponsor
- Professor Jørgen Berg Dahl
- Start
- Feb 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Ropivacaine adductor canal block with Placebo adductor canal block (2 arms). Primary endpoint: Total morphine requirement 0 to 24 hours postoperatively. Started Feb 2010; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2009-017794-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017794-37.